About this trial
This is a randomized study to evaluate the effectiveness and implementation of an intervention to decrease unnecessary urine testing for surgical patients (Less is More for Surgical Urine Testing) across six geographically diverse Veterans Affairs Medical Centers. The intervention will unfold over two years, in three phases: control, intervention, and sustainability.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Medical Centers part of the Veterans Affairs Health Administration (VAMCs)
VAMCs that perform standard, intermediate, or advanced surgical procedures
VAMCs in which perioperative urine testing is performed among greater than 10% of their non-urologic, non-transplant surgery procedures
Disqualifiers
VAMCs that only perform ambulatory surgery (outpatient/day surgery only)
VAMCs that do not perform urine testing among at least 10% of their non-urologic, non-transplant surgery procedures
VAMCs that already have implemented interventions to reduce perioperative urine testing
VAMCs' units performing genitourinary or transplant surgeries
Trial design
Sequential
Treatments tested in this trial
Interventional Project Site Visit
BehavioralActivities occurring during the 12-month intervention phase * 1:1 meetings introducing the project * Site Visit (once during intervention period) * Interactive teaching cases and didactic sessions * Distribution of algorithm as pocket cards * Access to project materials on SharePoint * Feedback reports on clinical outcomes * Evidence-based order set templates * Learning collaborative webinars * Individualized coaching
Treatment groups
Trial outcomes
Primary outcomes
Number of Urine Testing Performed
Throughout the study period, the research team will generate monthly lists of all urinalyses and urine cultures performed within 30 days before and 30 days after included procedures. The study team will chart review theses cases and determine whether the urine test was done on an asymptomatic patient or whether the test was justified based on UTI symptoms.
Secondary outcomes
Number of Days of Therapy
Days of therapy is an aggregate sum of days on which an antimicrobial agent was administered to an individual patient. The investigators will include systemic antibacterial agents administered within 30 days before and 30 days after surgery. The investigators will exclude doses given as standard preoperative prophylaxis and antimicrobial agents that are not used for urinary tract infections.
Budget Impact Analysis
Time spent by sites will be converted into cost by multiplying the hourly wage rate plus benefits for each type of healthcare professional involved in the intervention
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: